27th Annual SoCalBio
Investor & Partnering Conference
October 1 – 2, 2025 (PDT)
Hyatt Regency Newport Beach
Presenting Companies
AmplifiDx, Inc.
AmplifiDx is developing a best-in-class molecular point-of-care (POC) platform for rapid, affordable, and highly accurate infectious disease testing for Family & Women’s Health
Arc Medical
Arc Medical is A clinical stage company improving surgical patient recovery by preventing internal adhesions
ASiMA Health
Asima Health is developing a highly-sensitive, early detection, multi-cancer blood test to reduce the human and financial burden of cancer testing
Aufero Medical
Aufero is introducing TruContact, will be the first device on the market that actively enhancing catheter stability in cardiac ablation therapy
Avesta76 Therapeutics, Inc.
Avesta76 Therapeutics is advancing a novel cancer treatment that has demonstrated complete tumor elimination within 6 weeks in preclinical models.
CERN Corp
Develop and commercialize an effective, non-drug treatment for both fungal and bacterial vaginosis using low-level microbicidal light and an accompanying non-drug, photosensitizer/lubricant.
DimerX
NIH-backed, late-stage biopharmaceutical company leveraging a proprietary dimer technology platform to create novel, non-addictive therapeutics for acute and chronic pain, addressing high-impact, underserved medical needs.
FanousPhotonics
A cost-effective and compact digital pathology microscope to bridge the disparity between expensive, large and slow digital pathology scanners and the traditional pathology workflow that is manual, tedious, and prone to inaccuracies.
Hybrid Biotherapeutics
Pioneering a revolutionary approach
to cancer immunotherapy leveraging
the innate biological power of Hybrid
Neutrophils.
Ilya Pharma AB
Ilya Pharma is developing the future of local-acting immunotherapies and fighting disease by local instructions to immune cells and killing of multi drug resistant pathogens
Kidod Science
IVD device that would be one point of care diagnostic: one device that will diagnose multiple diseases in early stages using one sample.
Innovotex Inc
Innovotex is redefining cancer treatment with a clinically de-risked platform that precisely targets aggressive, treatment-resistant tumors.
Northern Vascular Systems
developing a light-activated liquid embolic platform. Our three part system is an investigational technology in early development as a novel approach to embolization.
Olive Bio
OliveBio’s mission is to solve the world’s plastic pollution crisis through making bioplastics manufacturing more scalable and cost-effective.
Persperion Diagnostics
Pretika MedTech Corporation
Pretika Medical is modernizing wound care management with “Connected” technology. An enabled medical device system and digital health technology.
Sonaro AI
Sonaro AI is developing 3D diagnostic ultrasound for vascular disease made simple and accessible
Squid Glaucoma hybridShunt
A hybrid device that combines features of a glaucoma drainage device (GDD) and minimally invasive glaucoma surgery (MIGS) device.
Sylamore Bio
SylamoreBio is a biotech company focused on delivering therapeutic modalities to CNS and other hard-to-treat tissues.
Trialynx
Trialynx is reimagining clinical trial development with agentic AI. We transform disjointed, siloed, error-prone, and costly processes into a collaborative, intelligent platform
Viridian Biometals
Viridian’s mission is to protect people and the planet while reducing the cost of refining metals critical to the energy transition.
THANK YOU TO OUR 2024 SPONSORS
